[go: up one dir, main page]

WO2007005249A3 - Nanoparticules et hydrogels a base de polymeres dendritiques les renfermant - Google Patents

Nanoparticules et hydrogels a base de polymeres dendritiques les renfermant Download PDF

Info

Publication number
WO2007005249A3
WO2007005249A3 PCT/US2006/023723 US2006023723W WO2007005249A3 WO 2007005249 A3 WO2007005249 A3 WO 2007005249A3 US 2006023723 W US2006023723 W US 2006023723W WO 2007005249 A3 WO2007005249 A3 WO 2007005249A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanoparticles
lens
relates
another aspect
ceramic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/023723
Other languages
English (en)
Other versions
WO2007005249A2 (fr
Inventor
Michael A Carnahan
Jeffrey A Clark
Mark W Grinstaff
Kenneth E Stockman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyperbranch Medical Technology Inc
Original Assignee
Hyperbranch Medical Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyperbranch Medical Technology Inc filed Critical Hyperbranch Medical Technology Inc
Publication of WO2007005249A2 publication Critical patent/WO2007005249A2/fr
Anticipated expiration legal-status Critical
Publication of WO2007005249A3 publication Critical patent/WO2007005249A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Selon un aspect, compositions à polymères et nanoparticules formant des hydrogels utiles comme matériaux de remplacement de lentille, de substitution de lentille, implants cornéens et lentilles intra-oculaires. On peut former les hydrogels avec une macromolécule de polyacrylate, de silicone ou dendritique. Parfois, ces hydrogels comportent des nanoparticules de diamètre compris entre environ 0,1 nm et environ 100 nm. En règle générale, les nanoparticules sont dispersées dans l'hydrogel et peuvent être à réticulation covalente ou non covalente. Elles peuvent être en métal, oxyde métallique ou en céramique. Parfois, elles comprennent un noyau de céramique revêtu d'une couche de silice. Selon un autre aspect, on décrit un procédé de formation de composition de lentille : traitement de mélange de composé dendrimère polymérisable et d'agent de polymérisation, ou encore on décrit une nanoparticule à noyau revêtu de couche de silice. Parfois, le noyau est en métal, oxyde métallique ou céramique. Enfin, un autre aspect concerne un kit de formation de lentille comprenant un composé dendrimère polymérisable, des nanoparticules et un système de délivrance de composé dendrimère et de nanoparticules à la poche de lentille du patient.
PCT/US2006/023723 2005-06-29 2006-06-19 Nanoparticules et hydrogels a base de polymeres dendritiques les renfermant Ceased WO2007005249A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69494405P 2005-06-29 2005-06-29
US60/694,944 2005-06-29

Publications (2)

Publication Number Publication Date
WO2007005249A2 WO2007005249A2 (fr) 2007-01-11
WO2007005249A3 true WO2007005249A3 (fr) 2009-04-16

Family

ID=37604937

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/023723 Ceased WO2007005249A2 (fr) 2005-06-29 2006-06-19 Nanoparticules et hydrogels a base de polymeres dendritiques les renfermant

Country Status (1)

Country Link
WO (1) WO2007005249A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
CN109912816B (zh) * 2019-03-05 2021-05-28 中原工学院 一种聚吡咯/聚氨酯复合导电水凝胶的制备方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1996243B1 (fr) 2006-01-11 2014-04-23 HyperBranch Medical Technology, Inc. Gels réticulés comprenant des polyalkylène-imines et utilisation de ceux-ci en tant que dispositifs médicaux
EP2502628B1 (fr) 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Séquences de polynucléotides et de polypeptides impliquées dans le cancer
US8262608B2 (en) 2007-01-25 2012-09-11 Hyperbranch Medical Technology, Inc. Applicators for multiple component formulations and the like, and methods of use thereof
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
EP2362908A4 (fr) 2008-11-03 2013-09-18 Alethia Biotherapeutics Inc Anticorps qui bloquent spécifiquement l'activité biologique d'un antigène tumoral
EP2396070B1 (fr) 2009-02-12 2024-12-04 Incept Llc Délivrance de médicament par bouchons d'hydrogels
US20100249273A1 (en) * 2009-03-31 2010-09-30 Scales Charles W Polymeric articles comprising oxygen permeability enhancing particles
CA2760704C (fr) 2009-05-04 2017-10-03 Incept, Llc Biomateriaux pour la fermeture de voie et de ponction
CN102844054B (zh) 2009-12-15 2016-04-20 因赛普特有限责任公司 植入物和能生物降解的基准标记物
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
EP3173427B1 (fr) 2011-03-31 2019-06-19 ADC Therapeutics SA Anticorps contre l'antigène 1 associé aux reins et leurs fragments de liaison à l'antigène
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
US20170174753A1 (en) 2012-01-09 2017-06-22 Alethia Biotherapeutics Inc. Method for treating breast cancer
WO2016065245A1 (fr) 2014-10-24 2016-04-28 Incept, Llc Échafaudage extraluminal
US20160166504A1 (en) 2014-12-10 2016-06-16 Incept, Llc Hydrogel drug delivery implants
JP2018515529A (ja) 2015-05-12 2018-06-14 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ ハイドロゲルからの薬物送達
CN108601725B (zh) 2015-11-25 2024-03-08 因赛普特有限责任公司 形状改变的药物递送装置和方法
US12171869B2 (en) 2016-09-23 2024-12-24 Incept, Llc Intracameral drug delivery depots
KR20220148869A (ko) * 2020-03-04 2022-11-07 다나-파버 캔서 인스티튜트 인크. 구조적으로 안정화된 항바이러스성 SARS-CoV-2 펩타이드 및 그의 용도
BR112023018676A2 (pt) 2021-03-18 2023-10-10 Seagen Inc Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco
CN114321939B (zh) * 2021-12-27 2023-04-14 北京北控绿海能环保有限公司 一种垃圾焚烧处理工艺
CN115322628B (zh) * 2022-06-30 2023-04-11 安徽登王化工有限公司 一种高耐磨氟碳粉末涂料及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040086479A1 (en) * 2001-02-26 2004-05-06 Duke University Novel dendritic polymers, crosslinked gels, and their biomedical uses
US20040096477A1 (en) * 2002-06-05 2004-05-20 Anuj Chauhan Ophthalmic drug delivery system
US20040131582A1 (en) * 2002-02-26 2004-07-08 Grinstaff Mark W. Novel dendritic polymers and their biomedical uses
US20040155312A1 (en) * 2001-06-20 2004-08-12 Wolfgang Muller-Lierheim Optical element, especially an eye implant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040086479A1 (en) * 2001-02-26 2004-05-06 Duke University Novel dendritic polymers, crosslinked gels, and their biomedical uses
US20040155312A1 (en) * 2001-06-20 2004-08-12 Wolfgang Muller-Lierheim Optical element, especially an eye implant
US20040131582A1 (en) * 2002-02-26 2004-07-08 Grinstaff Mark W. Novel dendritic polymers and their biomedical uses
US20040096477A1 (en) * 2002-06-05 2004-05-20 Anuj Chauhan Ophthalmic drug delivery system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205150B2 (en) 2011-12-05 2015-12-08 Incept, Llc Medical organogel processes and compositions
CN109912816B (zh) * 2019-03-05 2021-05-28 中原工学院 一种聚吡咯/聚氨酯复合导电水凝胶的制备方法

Also Published As

Publication number Publication date
WO2007005249A2 (fr) 2007-01-11

Similar Documents

Publication Publication Date Title
WO2007005249A3 (fr) Nanoparticules et hydrogels a base de polymeres dendritiques les renfermant
Cevik et al. The effect of silica and prepolymer nanoparticles on the mechanical properties of denture base acrylic resin
Hu et al. Hydrogel contact lens for extended delivery of ophthalmic drugs
Habib et al. Inorganic fillers for dental resin composites: present and future
Ren et al. Effects of aspirin-loaded graphene oxide coating of a titanium surface on proliferation and osteogenic differentiation of MC3T3-E1 cells
Alzayyat et al. Antifungal efficacy and physical properties of poly (methylmethacrylate) denture base material reinforced with SiO2 nanoparticles
McInnes et al. Controlled drug delivery from composites of nanostructured porous silicon and poly (L-lactide)
JP5918248B2 (ja) 有機無機複合フィラー、及びその製造方法
US20210214483A1 (en) Dental composite comprising glass ceramic
WO2005084637A3 (fr) Nouveaux procedes et nouvelle composition d'administration de macromolecules par voie orale
Elshenawy et al. Modification of glass-ionomer cement properties by quaternized chitosan-coated nanoparticles
CN106488753A (zh) 基于聚合的、断裂韧性的假体材料的铣削坯件
KR20140132694A (ko) 개선된 투명성을 갖는 내구성 치과용 재료
Mohammed et al. Enhancing the mechanical behaviour and antibacterial activity of bioepoxy using hybrid nanoparticles for dental applications
Abou Neel et al. Glass microparticle‐versus microsphere‐filled experimental dental adhesives
KR101991232B1 (ko) 지르코니아 필러의 표면개질방법 및 이를 함유하는 임시치아용 광경화수지 조성물
JP6806547B2 (ja) 歯科用硬化性組成物
ATE306539T1 (de) Zusammensetzungen zur textilpflege
JP7508315B2 (ja) 光造形用樹脂組成物
EA200702518A1 (ru) Композиции на основе наночастиц и с контролируемым высвобождением, включающие цефалоспорин
CN103937025A (zh) 含有治疗剂的隐形眼镜及其制备方法
Wei et al. Construction of zwitterionic coatings with lubricating and antiadhesive properties for invisible aligner applications
Chauhan Ocular drug delivery role of contact lenses
EA200800092A1 (ru) Композиции в виде наночастиц и с контролируемым высвобождением, включающие арил-гетероциклические соединения
JP2009204770A (ja) 眼用レンズ

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06773487

Country of ref document: EP

Kind code of ref document: A2